Conference abstract · 26 Oct 2015
EditorialPublished 2014
Patenting of Biosimilars?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Patenting biosimilars before the expiration of the original patent might raise several questions for the original manufacturer as well as the biosimilar manufacturer. In general, the most eminent questions are the drafting of the original patent in a way to be protected against a wide range of similar products and for the biosimilar manufacturer to ensure that the similar product is new and inventive. Since so far no case law exists in Europe dealing with biosimilars, both manufactures are somewhat in an unclear and ambiguous situation when it comes to estimate the scope of claims of biopharmaceuticals.
Subjects
Business & ManagementAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 19 Oct 2016
Impact of Biosimilars on Patent Portfolio Development and Management
Conference abstract · 27 Jun 2016
Dosing, double patenting and the US biosimilars landscape
Conference abstract · 27 Oct 2014
Biosimilars and emerging challenges: Navigating pathway to approval, patent issues, and the exclusivity period
Conference abstract · 27 Oct 2014
Can excluding pharmaceuticals from patenting will lead to cost effective and quality drugs/ biosimilars?
More from this journal
The newest in Intellectual Property Rights: Open Access.
Article · 18 Jun 2026
Patent Law and the Protection of Innovation in the Changing Intellectual Property Landscape
Article · 18 Jun 2026
Trademark Infringement and the Protection of Brand Identity in Intellectual Property Law
Article · 18 Jun 2026
The Debate on Copyright Abolition Within Intellectual Property Law
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIntellectual Property Rights: Open Access
- SubjectBusiness & Management
- BylineArticles whose byline prints “Heinz Mueller”

